Table 2.

ROC analysis for the prediction of endometriosis.

miRNAs	Disease stage	P value	AUC	Sensitivity (%)	Specificity (%)	95%CI
miR-199a	Ctrl versus All	<.001	0.621	54.55	98.61	0.550–0.705
miR-199a	Ctrl versus III, IV	<.001	0.698	67.29	94.29	0.615–0.782
miR-122	Ctrl versus All	<.001	0.756	45.75	97.40	0.694–0.817
miR-122	Ctrl versus I, II	<.001	0.715	68.42	63.64	0.614–0.816
miR-122	Ctrl versus III, IV	<.001	0.758	46.15	98.70	0.693–0.824
miR-122	I, II versus III, IV	.042	0.611	40.17	91.89	0.520–0.703
miR-9*	Ctrl versus All	.017	0.603	77.08	41.54	0.517–0.690
miR-9*	Ctrl versus I, II	<.001	0.718	91.67	49.25	0.627–0.810
miR-145*	Ctrl versus All	.01	0.612	85.33	38.10	0.524–0.699
miR-145*	Ctrl versus I, II	<.001	0.762	93.75	50.79	0.675–0.849
miR-141*	Ctrl versus All	.041	0.588	81.05	37.5	0.505–0.671
miR-542-3p	Ctrl versus All	.018	0.603	82.88	36.51	0.520–0.687
miR-199a, miR-122, miR-145*	Ctrl versus All	<.001	0.869	77.37	83.33	0.807–0.929
miR-199a, miR-122, miR-145*	Ctrl versus I, II	<.001	0.836	79.41	75.93	0.751–0.921
miR-199a, miR-122, miR-145*	Ctrl versus III, IV	<.001	0.879	79.61	83.33	0.818–0.941
miR-199a, miR-122, miR-145*, CA125	Ctrl versus All	<.001	0.939	81.75	92.59	0.898–0.980
miR-199a, miR-122, miR-145*, CA125	Ctrl versus I, II	<.001	0.753	70.59	79.63	0.646–0.860
miR-199a, miR-122, miR-145*, CA125	Ctrl versus III, IV	<.001	0.937	97.09	79.63	0.893–0.981
miR-199a, miR-122, miR-145*, CA125	I, II versus III, IV	<.001	0.759	79.61	73.53	0.652–0.866

miRNAs = microRNAs, ROC = receiver operating characteristics.